IMMUNE CHECKPOINT INHIBITORS
New Insights Into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
This review article provides a summary of the current knowledge about cardiovascular toxicities associated with immune checkpoint inhibitors and describes the underlying mechanisms associated with these adverse events.
Meet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
